Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
|Articles|August 25, 2020
Adolescent physical activity can improve hip strength and reduce risk of osteoporosis
Author(s)Lindsey Carr, Editor
A new study examined how adolescent physical activity can impact hip strength and potentially reduce the risk of osteoporosis later in life.
Advertisement
For the study—published in JAMA Network Open—researchers used a prospective birth cohort study that enrolled all pregnant women from 3 health authorities in Southwest England. A total of 15,454 women were enrolled and delivered 15,589 infants. Of those, 14,901 infants were alive at 1 year of age.
The researchers concluded that high-intensity physical activity could improve patients’ hip strength, which could prevent them from osteoporosis in their adult lives.
For more information on the findings and analysis, visit our sister publication,
Advertisement
Related to this article
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
Stephanie Faubion, MD, on the first menopause therapy discussion
4
Brain fog at menopause: Separating normal change from dementia
5